SCHEMBL11298255

SCHEMBL11298255

C=CC(=O)CCc1cccc(N(C)C)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.53
▸ ALOX15 P16050 3/20 0.53
▸ GAA P10253 1/20 0.53
▸ CNR1 P21554 1/20 0.48
▸ HDAC1 Q13547 1/20 0.45
▸ HDAC6 Q9UBN7 1/20 0.45
▸ KMT2A Q03164 3/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ MAPT P10636 3/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ MAPK1 P28482 2/20 0.40
▸ TSHR P16473 1/20 0.40
▸ NPC1 O15118 1/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ NFKB2 Q00653 1/20 0.39
▸ RELA Q04206 1/20 0.39
▸ MCL1 Q07820 1/20 0.39
▸ HDAC4 P56524 1/20 0.38
▸ MEF2D Q14814 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11301081 0.84 THRA (0.48) ALDH1A1ALOX15GAACNR1KMT2A
SCHEMBL7322435 0.81 ALDH1A1 (0.56) ALDH1A1ALOX15GAACNR1HDAC1
SCHEMBL29954798 0.81 ALDH1A1 (0.58) ALDH1A1ALOX15GAACNR1HDAC1
Hydrochloric Acid SCHEMBL10411183 0.80 ALDH1A1 (0.57) ALDH1A1ALOX15GAACNR1HDAC1
SCHEMBL6179341 0.80 ALDH1A1 (0.54) ALDH1A1ALOX15GAACNR1HDAC1
SCHEMBL11287913 0.79 ALDH1A1 (0.53) ALDH1A1ALOX15GAACNR1HDAC1
SCHEMBL4593938 0.75 ALDH1A1 (0.49) ALDH1A1ALOX15GAACNR1HDAC1
SCHEMBL27908866 0.75 FFAR1 (0.49) GAAMAPTGPR52
SCHEMBL3049598 0.75 NPSR1 (0.38) ALDH1A1ALOX15GAAMAPTSMN1; SMN2
SCHEMBL10411875 0.75 CYP4F2 (0.53) ALDH1A1ALOX15GAACNR1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0043141-A1 Pharmaceutical compositions having antiviral activity for topical administration and the use of 1-(substituted phenyl)-5-(4-morpholinyl)-1-penten-3-one compounds for the preparation of pharmaceutical compositions having an antiviral effect MERRELL DOW PHARMACEUTICALS INC. (US) 1982-01-06 — — EP disclosed
Send feedback